AKBR MEDICAL LIMITED
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (70/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2025-03-31 |
|---|---|
| Average employees | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
Corporate timeline (10 events)Click to expand
- 2025-12-24📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-04-03📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2025-03-06📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-04-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-05-16📄capital-allotment-sharescapital · SH01
- 2023-05-12📄memorandum-articlesincorporation · MA
- 2023-05-12📄resolutionresolution · RESOLUTIONS
- 2022-07-19🏢Company incorporatedAs AKBR MEDICAL LIMITED
- 2022-07-19➕RUTHVEN, Alasdair, Dr appointeddirector
- 2022-07-19📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Alasdair Ruthven Individual · British · DOB 10/1984 · age 42 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 19/07/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A.E.N. LIMITED→ SC256550 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| AADENT 1 LIMITED→ SC868082 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ACUPUNCTURE & HEALTH CENTRE LTD→ SC383161 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| ADHDDEGREE LTD→ SC822923 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AGE ETERNAL LIMITED→ SC767087 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AGE SCOTLAND→ SC153343 · est 1994 · no financials extracted | — | — | — | — | 31y | — | — |
| AILSA CARE SERVICES LTD.→ SC272779 · est 2004 · no financials extracted | — | — | — | — | 21y | — | — |
| ALKETA BOUZI LIMITED→ SC884347 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ALL CARE SERVICES LTD→ SC599935 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ALMOND BLOSSOM CARE LIMITED→ SC515316 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| ALMOND VALLEY CARE LIMITED→ SC733638 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ALPHAMED SCOTLAND LIMITED→ SC688804 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.